Stay updated on Pembrolizumab+Lenvatinib vs Chemo in Endometrial Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab+Lenvatinib vs Chemo in Endometrial Carcinoma Clinical Trial page.

Latest updates to the Pembrolizumab+Lenvatinib vs Chemo in Endometrial Carcinoma Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3, indicating an updated version of the record history display.SummaryDifference0.0%

- Check15 days agoChange DetectedThe page footer revision indicator updated from v3.6.0 to v3.6.2. This represents a small platform/UI update rather than any changes to the study information or user interactions.SummaryDifference0.0%

- Check29 days agoChange DetectedA new revision entry v3.6.0 has been added, and the recruitment note 'No longer looking for participants' has been added to the record. The previous revision v3.5.5 has been removed.SummaryDifference0.1%

- Check36 days agoChange DetectedThe page now shows Revision: v3.5.5 instead of v3.5.4, reflecting a new site release. This change updates the page metadata without altering study content.SummaryDifference0.0%

- Check57 days agoChange DetectedThe page history shows the revision tag updated from v3.5.3 to v3.5.4, indicating a platform release rather than a change to the study data.SummaryDifference0.0%

- Check72 days agoChange DetectedThe page now shows Revision: v3.5.3, replacing the previous v3.5.2. This indicates the study history record has been updated to a newer version.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab+Lenvatinib vs Chemo in Endometrial Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Lenvatinib vs Chemo in Endometrial Carcinoma Clinical Trial page.